Screener
Assembly Biosciences ASMB Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses | ||
| Research and development | 14,900 | 14,851 |
| General and administrative | 4,683 | 4,509 |
| Total operating expenses | 19,583 | 19,360 |
| Loss from operations | (11,370) | (9,941) |
| Other income | ||
| Interest and other income, net | 2,291 | 1,123 |
| Total other income | 2,291 | 1,123 |
Item 1. Financial Statements
FAQ
- What is Assembly Biosciences's other operating expenses?
- Assembly Biosciences (ASMB) reported other operating expenses of $19.58M in Q1 2026.
- How has Assembly Biosciences's other operating expenses changed year-over-year?
- Assembly Biosciences's other operating expenses increased by 1.2% year-over-year, from $19.36M to $19.58M.
- What is the long-term trend for Assembly Biosciences's other operating expenses?
- Over 4 years (2021 to 2025), Assembly Biosciences's other operating expenses has grown at a -11.7% compound annual growth rate (CAGR), from $138.94M to $84.42M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Assembly Biosciences's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude